Articles by James Calloway
Wix Secures $250M Investment, Posts Mixed Q4 Results, and Unveils 2026 Outlook
Wix has entered into a $250 million private placement agreement and reported fourth-quarter revenue of $524.3 million, a 14% increase. The company also issued a 2026 outlook projecting mid-teens growth.
Adidas Shares Slide on 2026 Profit Guidance Miss, CEO Contract Extended
Adidas AG shares dropped sharply after the company projected 2026 operating profit of approximately €2.3 billion, missing analyst expectations. The sportswear giant pointed to U.S. import tariffs and a weaker dollar as primary challenges.
CrowdStrike Posts Strong Q4, Guides Higher Amid AI Security Focus
CrowdStrike Holdings reported fourth-quarter results that exceeded profit expectations and raised its annual recurring revenue target. The cybersecurity firm also issued forward-looking revenue guidance for fiscal 2027 and disclosed new share repurchases.
Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision
Eli Lilly shares declined for a second day as the market anticipates an FDA decision on its oral obesity treatment in April. The FDA also issued warnings to telehealth firms marketing compounded weight-loss drugs.
CrowdStrike Stock Gains on Strong Q4 Results and Upbeat Long-Term Targets
CrowdStrike reported better-than-expected fourth-quarter results, with annual recurring revenue exceeding $5 billion. The company provided a robust long-term forecast through fiscal 2027, sending shares higher in extended trading.
Broadcom Shares Dip Ahead of Q1 Report Amid RBC Target Cut, AI Demand Scrutiny
Broadcom shares declined 1.6% to $313.84 Tuesday, with RBC Capital reducing its price target to $340 from $370 ahead of the chipmaker's quarterly results. The market is focused on AI infrastructure spending durability and VMware software growth.
Adobe Shares Surge Ahead of Q1 Earnings, AI Monetization in Focus
Adobe shares gained 4.1% on Tuesday, defying broader market weakness, as investors look to the company's upcoming earnings report for clarity on AI monetization and acquisition progress.
Credo Technology Shares Plunge on Margin Guidance Despite Record Sales
Credo Technology shares dropped sharply after the company projected a decline in gross margins for the current quarter, overshadowing record fiscal Q3 revenue and an acquisition.
MongoDB Plunges on Soft Guidance and Sales Leadership Overhaul
MongoDB shares tumbled over 21% following a cautious first-quarter outlook and management shifts in its sales organization. Analyst firm Baird downgraded the stock, citing concerns over Atlas growth.
ImmunityBio Shares Dip Ahead of Key Business Update Call
ImmunityBio shares edged lower in premarket activity Tuesday, giving back some of the prior session's gains ahead of a scheduled business update and full-year results call later in the day.
Target Projects 2026 Sales Rebound as New CEO Charts Turnaround
Target Corporation has issued a 2026 outlook projecting a return to net sales growth of approximately 2%, alongside an earnings per share forecast between $7.50 and $8.50. The retailer's shares advanced 5.5% in premarket trading following the announcement.